Hepatology
From the Journals
Screen all adults for hepatitis C, says USPSTF
The U.S. Preventive Services Task Force now recommends that asymptomatic adults ages 18-79 be screened for hepatitis C virus infection.
Latest News
Expert: Eliminating HCV ‘sounds ambitious, but I think it’s possible’
An estimated one in three inmates in the United States has chronic HCV.
Conference Coverage
HBV: Rethink the free pass for immune tolerant patients
MAUI, HAWAII – Not treating means more liver cancer.
Conference Coverage
NASH ‘an epidemic of the 21st century’
LOS ANGELES – Recent guidelines recognize the association between diabetes, NAFLD, and NASH, and call for more vigilance and screening tests.
Conference Coverage
Novel approaches to treating NASH in diabetes
BARCELONA –
Conference Coverage
What’s new in hepatitis C: Four themes that dominated at the Liver Meeting
BOSTON – AASLD highlights included treatment of persons who inject drugs, new directions in pangenotypic therapy,...
Latest News
AASLD debrief: Five drugs show promise in NAFLD (and two do not)
BOSTON – Promising new data for cotadutide, licogliflozin, tropifexor, saroglitazar, and PF-05221304 highlighted in...
Conference Coverage
TARGET-NASH: One-third of NAFLD, NASH patients lost weight, but not all kept it off
BOSTON – With no approved pharmacologic treatments for NAFLD and NASH, weight reduction remains one of the mainstays of treatment.
Conference Coverage
ED-based HCV screening found feasible, linkage low
BOSTON – Among patients with homes, linkage to care was 59%, compared with 20% for patients who were homeless.
Conference Coverage
Hepatitis B debrief: Key themes that emerged at AASLD
BOSTON – Hot topics included HBV natural history, novel therapies, and prevention.
Conference Coverage
Kratom: Botanical with opiate-like effects increasingly blamed for liver injury
BOSTON – Kratom-associated liver damage involves a mixed pattern of hepatocellular and cholestatic injury.